- Home
- PLRX vs SWBI Comparison
PLRX vs SWBI Comparison
Compare PLRX & SWBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLRX | SWBI |
|---|---|---|
| Founded | 2015 | 1852 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Ordnance And Accessories |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.3M | 453.6M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | PLRX | SWBI |
|---|---|---|
| Price | $1.26 | $10.24 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 1 |
| Target Price | $3.79 | ★ $11.00 |
| AVG Volume (30 Days) | ★ 1.9M | 822.0K |
| Earning Date | 11-06-2025 | 12-04-2025 |
| Dividend Yield | N/A | ★ 5.01% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.21 |
| Revenue | N/A | ★ $466,396,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.56 |
| P/E Ratio | ★ N/A | $49.59 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.10 | $7.73 |
| 52 Week High | $14.30 | $11.50 |
Technical Indicators
Market Signals| Indicator | PLRX | SWBI |
|---|---|---|
| Relative Strength Index (RSI) | 37.82 | 56.61 |
| Support Level | $1.20 | $10.62 |
| Resistance Level | $1.30 | $11.23 |
| Average True Range (ATR) | 0.11 | 0.42 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 18.27 | 55.12 |
Price Performance
Historical ComparisonAbout PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
About SWBI Smith & Wesson Brands Inc.
Smith & Wesson Brands Inc is a U.S.-based leader in firearm manufacturing. It operates under one reportable segment: Firearms, which includes firearms distribution and manufacturing services. The company manufactures handguns, long guns, sporting rifles, shooting gear, and suppressor products. The firm's brand portfolio consists of Smith and Wesson, M&P, Thompson/Center Arms, Performance Center, and Gemtech; which are used for defense, law enforcement, hunting, and sporting purposes. The company operates internationally, with the majority of income generated by the U.S. market from its handgun products.